If JavaScript is turned off, turn it on.

Japanese

Products Information

News Releases

News releases issued by Kyowa Kirin are intended to inform stakeholders of information related to the company's business in a fair manner. Though it may include information concerning pharmaceutical products (including products under development) , it is not for the purpose of promoting, advertising or medical advice.

2022

December 27, 2022

［Pharmaceuticals domain］
Kyowa Kirin Announces Approval of Topical Ophthalmic Mitomycin C Agent in Japan PDF:277KB
December 26, 2022
- CSV
Notice Regarding Execution of the First Transition-Linked Loan for a Japanese food and beverages company
December 23, 2022

［Pharmaceuticals domain］
- IR
Kyowa Kirin to Decide on Construction of a New Warehouse Building at its Takasaki Plant PDF:318KB
December 23, 2022

［Pharmaceuticals domain］
- CSV
Kyowa Kirin’s Ube Plant to Introduce Large-Scale Solar Power Generation System PDF:336KB
December 23, 2022

［Food & Beverages domain］
- Other
Global Beer Consumption by Country in 2021
December 14, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Announces Lancet Publication of Phase 2b Study Results for Rocatinlimab (KHK4083/AMG 451) in Adult Patients with Moderate-to-Severe Atopic Dermatitis PDF:435KB
December 7, 2022

［Pharmaceuticals domain］
- IR
- Products and Services
Kyowa Kirin Announces Launch of “G-Lasta® Subcutaneous Injection 3.6 mg BodyPod” in Japan PDF:208KB
December 7, 2022

［Pharmaceuticals domain］
- IR
Notice Concerning Revisions to Financial Earnings Forecast PDF:133KB
December 7, 2022

［Pharmaceuticals domain］
- IR
MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting PDF:221KB
November 30, 2022

［Food & Beverages domain］
- Products and Services
Price Revisions For Certain Imported Whiskies and Spirits, RTDs, And Kegged Products
November 25, 2022

［Health Science domain］
- Products and Services
- Research and Technology
Completion Of Human Milk Oligosaccharides (HMOs) Production Facility
November 24, 2022
- Human Resources
Kirin Holdings Recognized By The PRIDE Index As An LGBTQ+-friendly Workplace, Receiving Gold Status For The Sixth Year In A Row
November 24, 2022
- Research and Technology
New Cleansing Agent Development Process Utilizing AI And Molecular Simulation Technologies Examined: Collaboration with Kirin Holdings, FANCL, and Keio University
November 18, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japan PDF:296KB
November 18, 2022

［Food & Beverages domain］
- Products and Services
Château Mercian Mariko Winery Chosen Yet Again By “World’s Best Vineyards 2022”
November 14, 2022

［Pharmaceuticals domain］
- IR
Kyowa Kirin Announces Application for Partial Change of Romiplate® for Aplastic Anemia in Japan PDF:234KB
November 11, 2022

［Health Science domain］
- CSV
- Research and Technology
Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
November 11, 2022

［Health Science domain］
- CSV
The KIRIN HEALTH INNOVATION FUND Invests In BackTech, Developer Of Pocket Therapist® , A Labor Productivity Improvement Support Service For Employees
November 9, 2022
- CSV
Kirin Holdings Signs the COP15 Business Statement for Mandatory Assessment and Disclosure
October 31, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Announces NDA Submission of Tenapanor Hydrochloride (KHK7791) for Improvement of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis in Japan PDF:285KB
October 21, 2022

［Pharmaceuticals domain］
- Research and Technology
Kyowa Kirin Announces Presentations of the Results of Phase 3 Studies of Tenapanor Hydrochloride (KHK7791) for Hemodialysis Patients with Hyperphosphatemia in Japan at the American Society of Nephrology Meeting PDF:314KB
October 19, 2022

［Health Science domain］
- CSV
- Products and Services
Kirin Expands Lineup Of Functional Food Products for Immune Function With L. lactis strain Plasma To 38, More Than Double
October 18, 2022
- Other
OMRON Invests In Kirin Techno-System, a Comprehensive Manufacturer Of Inspection Machines
October 6, 2022

［Pharmaceuticals domain］
- IR
- Research and Technology
Kyowa Kirin Initiated CVC PDF:207KB
October 3, 2022
- CSV
Kirin Holdings To Participate In The Ministry of the Environment’s 30by30 Alliance For Biodiversity Through The Mariko Vineyard
September 30, 2022

［Health Science domain］
- CSV
iMUSE Wins 2022 Product of the Year Award in the Immune Support Category at the Nutralngredients-Asia Awards
September 29, 2022

［Food & Beverages domain］
- Products and Services
Consulting Business For Start-up Wineries
September 21, 2022
- IR
(Progress of disclosed matters) Withdrawal of Filings for Commercial Arbitration and Liquidation in Regards to the Myanmar Business PDF:227.4KB
September 16, 2022

［Pharmaceuticals domain］
- Products and Services
- Research and Technology
Kyowa Kirin Announces Application for Partial Change of Approved Indication of LUMICEF® for Palmoplantar Pustulosis in Japan PDF:267KB
September 15, 2022
- Human Resources
Kirin Holdings Engages With The Human Capital Management Consortium As A Promoter

Next 1 2 3 4

Next 1 2 3 ... 4

Archives